Niagen Bioscience, Inc. (NAGE) — Capital Reinvestment Ratio
Niagen Bioscience, Inc. (NAGE) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($3.69 Million) in capital expenditures ($24.00K). Check Niagen Bioscience, Inc. (NAGE) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Niagen Bioscience, Inc. Capital Reinvestment Ratio (2023–2024)
This chart tracks Niagen Bioscience, Inc.'s Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see NAGE operating cash flow.
Annual Capital Reinvestment Ratio for Niagen Bioscience, Inc. (2023–2024)
Year-by-year Capital Reinvestment Ratio for Niagen Bioscience, Inc. from 2023 to 2024. See NAGE cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $12.11 Million | $163.00K | ▼ -35.3% |
| 2023 | 0.02x | $7.12 Million | $148.00K | — |